Skip navigationU.S. Food and Drug Administration Center for Drug Evaluation and Research

CDER - Center for Drug Evaluation and Research Logo

Office of Generic Drugs

Reference Listed Drug Labeling and Efficacy Supplements Approved in December 2002

Click on appropriate hyperlink below to view available source document in PDF format

Approval

Date

Product Name

Source Documents

Active Ingredient(s)/Dosage Form

Document ID No.

Dec 2

VIREAD

letter label

tenofovir disoproxil fumarate tablets

21-356 SLR 001

AVANDIA

letter   

rosiglitazone maleate tablets

21-071 SLR 008

Dec 3

PREVACID

letter  

lansoprazole delayed-release capsules

21-281 SLR 004

    

PREVACID

letter  

lansoprazole oral suspension

20-406 SLR 048

Dec 4

ARIXTRA

letter label

fondaparinux Na injection

21-345 SLR 001

Dec 5

RYTHMOL

letter  

propafenone HCl tablets

19-151 SLR 009

Dec 11

ULTANE

letter  

sevoflurane

20-478 SLR 007

Dec 12

HELIDAC

letter  

bismuth subsalicylate/ metronidazole/ tetracycline HCl

50-719 SLR 006

 

TRINALIN

letter  

azatadine maleate/seudoephedrine sulfate tablets

18-506 SLR 025

 

ALDARA

letter label

imiquimod cream

20-723 SLR 010

ELOCON

letter label

mometasone furoate ointment

19-543 SLR 014

Dec 15

MYCELEX

letter label

clotrimazole troche

18-713 SLR 019

PERIOCHIP

letter   

chlorhexidine gluconate

20-774 SLR 003

  

STATICIN

letter label

erythromycin topical solution

50-526 SLR 010

   

BECONASE

letter  

beclomethasone dopropionate nasal spray

18-584 SLR 026

 

BECONASE AQ

letter  

beclomethasone dopropionate nasal spray

19-389 SLR 025

Dec 16

PLEGISOL

letter  

cardioplegic solution

18-608 SLR 031

  

PRILOSEC

letter  

omeprazole delayed-release capsules

19-810 SLR 076

   

UREAPHIL

letter  

urea injection

12-154 SLR 023

   

ZYFLO

letter  

zileutin tablets

20-471 SLR 009

Dec 17

LOTRISONE

letter  

clotrimazole/betamethasone diproprionate lotion

20-010 SLR 003

  

CEFOBID

letter  

cefoperazone Na injection

50-551 SLR 042

   

CLOZARIL

letter  

clozapine tablets

19-758 SE1 047

Dec 18

MONUROL

letter  

fosfomycin tromethamine sachet

50-717 SLR 004

      

RETROVIR

letter  

zidovudine capsules

19-655 SLR 038

     

RETROVIR

letter  

zidovudine syrup

20-518 SLR 010

     

BECONASE AQ

letter  

beclomethasone dopropionate nasal spray

19-389 SLR 021

   

IMURAN

letter  

azathioprine injection

17-391 SLR 011

   

IMURAN

letter  

azathioprine tablets

16-324 SLR 026

Dec 19

TEQUIN

letter   

gatifloxacin tablets

21-062 SLR 015

   

TEQUIN

letter  

gatifloxacin injection

21-061 SLR 015

  

ZYVOX

letter  

linezolid tablets

21-130 SLR 002

  

ZYVOX

letter  

linezolid injection

21-131 SLR 002

   

ZYVOX

letter  

linezolid oral suspension

21-132 SLR 002

  

COLY-MYCIN M

letter  

colistimethate injection

50-108 SLR 023

  

CORTISPORIN

letter  

polymyxin B sulfate/neomycin sulfate/hydrocortisone acetate cream

50-218 SLR 051

  

DEPAKOTE ER

letter  

divalproex extended-release tablets

21-168 SLR 004

Dec 20

GLEEVEC

letter label

imatinib mesylate capsules

21-335 SE1 004

  

MATULANE

letter  

procarbazine HCl) Capsules

16-785 SLR 035

  

OLUX FOAM

letter  

clobetasol propionate foam

21-142 SE1 004

  

XALATAN

letter  

latanoprost ophthalmic solution

20-597 SE1 010

  

ZONALON

letter  

doxepin HCl cream

20-126 SLR 006

Dec 23

BUSULFEX

letter  

busulfan injection

20-954 SLR 001

  

PHENERGAN

letter  

promethazine HCl suppositories

10-926 SLR 022

Dec 26

PHENERGAN

letter  

promethazine HCl

11-689 SLR 020

  

PHENERGAN

letter  

promethazine HCl tablets

07-935 SLR 028

  

SINGULAIR

letter  

montelukast Na tablets

20-829 SE1 017

  

SINGULAIR

letter  

montelukast Na oral granules

21-409 SE1 003

Dec 31

SINGULAIR

letter  

montelukast Na chewable tablets

20-830 SE1 020

  

VIRAMUNE

letter  

nevirapine tablets

20-636 SLR 016

    

VIRAMUNE

letter  

nevirapine suspension

20-933 SLR 006

totop.gif (1525 bytes) Back to Top

Back Labeling Review  Branch Page

FDA/Center for Drug Evaluation and Research
Last Updated: January 18, 2006
Originator: OTCOM/DLIS
HTML by JFG